Literature DB >> 24487013

Nicotine administration in adolescence reprograms the subsequent response to nicotine treatment and withdrawal in adulthood: sex-selective effects on cerebrocortical serotonergic function.

Theodore A Slotkin1, Jennifer Card2, Frederic J Seidler2.   

Abstract

Nicotine exposure in adolescence produces lasting changes in subsequent behavioral responses to addictive agents. We gave nicotine to adolescent rats (postnatal days PN30-47), simulating plasma levels in smokers, and then examined the subsequent effects of nicotine given again in adulthood (PN90-107), focusing on cerebrocortical serotonin levels and utilization (turnover) as an index of presynaptic activity of circuits involved in emotional state. Our evaluations encompassed responses during the period of adult nicotine treatment (PN105) and withdrawal (PN110, PN120, PN130), as well as long-term changes (PN180). In males, prior exposure to nicotine in adolescence greatly augmented the increase in serotonin turnover evoked by nicotine given in adulthood, an interaction that was further exacerbated during withdrawal. The effect was sufficiently large that it led to significant depletion of serotonin stores, an effect that was not seen with nicotine given alone in either adolescence or adulthood. In females, adolescent nicotine exposure blunted or delayed the spike in serotonin turnover evoked by withdrawal from adult nicotine treatment, a totally different effect from the interaction seen in males. Combined with earlier work showing persistent dysregulation of serotonin receptor expression and receptor coupling, the present results indicate that adolescent nicotine exposure reprograms future responses of 5HT systems to nicotine, changes that may contribute to life-long vulnerability to relapse and re-addiction.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adolescence; Nicotine; Serotonin; Sex differences; Withdrawal

Mesh:

Substances:

Year:  2014        PMID: 24487013      PMCID: PMC3972282          DOI: 10.1016/j.brainresbull.2014.01.004

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  55 in total

Review 1.  Role of serotonin and other neurotransmitter receptors in brain development: basis for developmental pharmacology.

Authors:  P M Whitaker-Azmitia
Journal:  Pharmacol Rev       Date:  1991-12       Impact factor: 25.468

2.  Roles for neurotransmitters in development: possible interaction with drugs during the fetal and neonatal periods.

Authors:  J M Lauder
Journal:  Prog Clin Biol Res       Date:  1985

Review 3.  Synaptic development of the cerebral cortex: implications for learning, memory, and mental illness.

Authors:  P Rakic; J P Bourgeois; P S Goldman-Rakic
Journal:  Prog Brain Res       Date:  1994       Impact factor: 2.453

4.  Saying "goodbye" to the "crack baby".

Authors:  C D Coles
Journal:  Neurotoxicol Teratol       Date:  1993 Sep-Oct       Impact factor: 3.763

5.  Behavioral and neurochemical vulnerability during adolescence in mice: studies with nicotine.

Authors:  Walter Adriani; Oleg Granstrem; Simone Macri; Galina Izykenova; Svetlana Dambinova; Giovanni Laviola
Journal:  Neuropsychopharmacology       Date:  2004-05       Impact factor: 7.853

6.  Age of smoking initiation: implications for quitting.

Authors:  J Chen; W J Millar
Journal:  Health Rep       Date:  1998       Impact factor: 4.796

7.  Ventricular size and intelligence in achondroplasia.

Authors:  B L Priestley; J Lorber
Journal:  Z Kinderchir       Date:  1981-12

8.  Fetal nicotine or cocaine exposure: which one is worse?

Authors:  T A Slotkin
Journal:  J Pharmacol Exp Ther       Date:  1998-06       Impact factor: 4.030

Review 9.  Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates.

Authors:  Theodore A Slotkin
Journal:  Toxicol Appl Pharmacol       Date:  2004-07-15       Impact factor: 4.219

10.  Effects of transderman nicotine on mood and sleep in nonsmoking major depressed patients.

Authors:  R J Salín-Pascual; J R de la Fuente; L Galicia-Polo; R Drucker-Colín
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

View more
  5 in total

1.  Chronic fluoxetine ameliorates adolescent chronic nicotine exposure-induced long-term adult deficits in trace conditioning.

Authors:  David A Connor; Thomas J Gould
Journal:  Neuropharmacology       Date:  2017-08-02       Impact factor: 5.250

Review 2.  Nicotine and the adolescent brain.

Authors:  Menglu Yuan; Sarah J Cross; Sandra E Loughlin; Frances M Leslie
Journal:  J Physiol       Date:  2015-06-23       Impact factor: 5.182

3.  Sex differences in neurotensin and substance P following nicotine self-administration in rats.

Authors:  Steven T Pittenger; Natashia Swalve; Shinnyi Chou; Misty D Smith; Amanda J Hoonakker; Cindy M Pudiak; Annette E Fleckenstein; Glen R Hanson; Rick A Bevins
Journal:  Synapse       Date:  2016-05-04       Impact factor: 2.562

Review 4.  Hormonal Imprinting: The First Cellular-level Evidence of Epigenetic Inheritance and its Present State.

Authors:  György Csaba
Journal:  Curr Genomics       Date:  2019-09       Impact factor: 2.236

5.  Exposure of Neonatal Mice to Tobacco Smoke Disturbs Synaptic Proteins and Spatial Learning and Memory from Late Infancy to Early Adulthood.

Authors:  Larissa Helena Torres; Raphael C T Garcia; Anne M M Blois; Lívia M M Dati; Ana Carolina Durão; Adilson Silva Alves; Maurílio Pacheco-Neto; Thais Mauad; Luiz R G Britto; Gilberto Fernando Xavier; Rosana Camarini; Tania Marcourakis
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.